X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4258) 4258
Publication (214) 214
Book Review (18) 18
Book Chapter (4) 4
Conference Proceeding (4) 4
Newsletter (4) 4
Magazine Article (2) 2
Book / eBook (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alprostadil - pharmacology (2682) 2682
animals (2403) 2403
humans (2042) 2042
male (1705) 1705
female (1040) 1040
rats (1001) 1001
alprostadil (889) 889
alprostadil - analogs & derivatives (827) 827
prostaglandins e - pharmacology (789) 789
adult (555) 555
in vitro techniques (511) 511
middle aged (487) 487
cyclic amp - metabolism (468) 468
mice (468) 468
dose-response relationship, drug (462) 462
cells, cultured (405) 405
alprostadil - administration & dosage (400) 400
alprostadil - therapeutic use (387) 387
pharmacology & pharmacy (375) 375
dinoprostone - pharmacology (370) 370
kinetics (370) 370
index medicus (351) 351
rats, inbred strains (323) 323
prostaglandin e (321) 321
biochemistry & molecular biology (315) 315
aged (285) 285
platelet aggregation - drug effects (283) 283
time factors (282) 282
rabbits (280) 280
epoprostenol - pharmacology (272) 272
adenylyl cyclases - metabolism (261) 261
blood platelets - drug effects (260) 260
vasodilator agents - pharmacology (259) 259
cell line (258) 258
colforsin - pharmacology (258) 258
dogs (253) 253
dinoprostone (238) 238
indomethacin - pharmacology (233) 233
prostaglandins (231) 231
prostaglandins - pharmacology (230) 230
alprostadil - metabolism (223) 223
isoproterenol - pharmacology (212) 212
blood platelets - metabolism (209) 209
blood pressure - drug effects (183) 183
rats, wistar (183) 183
misoprostol (176) 176
prostaglandin e1 (161) 161
bucladesine - pharmacology (158) 158
cell biology (154) 154
rats, sprague-dawley (154) 154
pregnancy (153) 153
platelet aggregation inhibitors - pharmacology (149) 149
prostaglandins e, synthetic - pharmacology (146) 146
dinoprost (137) 137
calcium - metabolism (136) 136
prostaglandins f - pharmacology (134) 134
cyclic amp - biosynthesis (132) 132
guinea pigs (131) 131
epinephrine - pharmacology (130) 130
expression (127) 127
adenosine diphosphate - pharmacology (126) 126
endocrinology & metabolism (125) 125
hemodynamics - drug effects (125) 125
research article (116) 116
drug synergism (115) 115
prostaglandin (115) 115
vasodilator agents - administration & dosage (115) 115
1-methyl-3-isobutylxanthine - pharmacology (114) 114
physiology (114) 114
surgery (113) 113
cyclic amp - blood (110) 110
lipids (109) 109
anti-ulcer agents - pharmacology (106) 106
dinoprostone - metabolism (106) 106
vasodilator agents - therapeutic use (106) 106
cholera toxin - pharmacology (105) 105
regional blood flow - drug effects (105) 105
tetradecanoylphorbol acetate - pharmacology (105) 105
dinoprost - pharmacology (104) 104
tumor cells, cultured (104) 104
cyclic amp (103) 103
infusions, intravenous (103) 103
signal transduction (102) 102
activation (101) 101
cell division - drug effects (100) 100
hematology (100) 100
phosphorylation (99) 99
disease models, animal (95) 95
blood platelets - physiology (94) 94
immunology (94) 94
double-blind method (92) 92
drug interactions (92) 92
enzyme activation - drug effects (92) 92
cyclic amp - pharmacology (91) 91
receptors, prostaglandin e - metabolism (91) 91
theophylline - pharmacology (91) 91
prostaglandins e (89) 89
cyclic amp - physiology (88) 88
dinoprostone - analogs & derivatives (88) 88
inhibition (88) 88
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3958) 3958
Japanese (159) 159
Russian (51) 51
Chinese (32) 32
German (20) 20
Italian (20) 20
French (13) 13
Spanish (11) 11
Portuguese (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Hungarian (1) 1
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thorax, ISSN 0040-6376, 12/2011, Volume 66, Issue 12, pp. 1029 - 1035
Journal Article
Circulation Research: Journal of The American Heart Association, ISSN 0009-7330, 03/2004, Volume 94, Issue 5, pp. 592 - 600
ABSTRACT—Hyaluronic acid (HA) is a prominent constituent of the extracellular matrix of atherosclerotic vascular lesions in humans known to modulate vascular... 
Extracellular matrix | Prostaglandins | Cyclooxygenase-2 | Hyaluronic acid | Atherosclerosis | atherosclerosis | MIGRATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PERICELLULAR MATRIX | SUBTYPES | cyclooxygenase-2 | EPIDERMAL-KERATINOCYTES | hyaluronic acid | CAROTID ARTERIES | GROWTH-FACTOR-BETA | PROSTANOID RECEPTORS | prostaglandins | PERIPHERAL VASCULAR DISEASE | MOLECULAR-CLONING | HEMATOLOGY | EXPRESSION | extracellular matrix | Iloprost - pharmacology | Cyclooxygenase 2 | Humans | Muscle Cells - drug effects | Maleimides - pharmacology | Extracellular Matrix - metabolism | Alprostadil - analogs & derivatives | Cyclic AMP - physiology | Glucuronosyltransferase - genetics | RNA, Messenger - biosynthesis | Macrophages - secretion | Isoquinolines - pharmacology | Carotid Artery Diseases - pathology | Hyaluronic Acid - biosynthesis | Acetophenones - pharmacology | Enzyme Induction - drug effects | Epoprostenol - pharmacology | Indoles - pharmacology | Hyaluronan Synthases | Benzopyrans - pharmacology | Carotid Artery, Internal - pathology | Isoenzymes - physiology | Muscle, Smooth, Vascular - drug effects | Pertussis Toxin - pharmacology | Cells, Cultured - drug effects | Vasodilator Agents - pharmacology | Colforsin - pharmacology | Proto-Oncogene Proteins c-sis | RNA, Small Interfering - pharmacology | Alprostadil - pharmacology | Receptors, Prostaglandin E - drug effects | 6-Ketoprostaglandin F1 alpha - biosynthesis | Platelet-Derived Growth Factor - pharmacology | Cells, Cultured - secretion | Membrane Proteins | Epoprostenol - analogs & derivatives | Hyaluronic Acid - secretion | Sulfonamides | Receptors, Prostaglandin E, EP2 Subtype | Arteriosclerosis - metabolism | Bucladesine - pharmacology | Muscle, Smooth, Vascular - secretion | Arteriosclerosis - pathology | Glucuronosyltransferase - biosynthesis | Muscle Cells - secretion | Prostaglandin-Endoperoxide Synthases - physiology
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 10/2004, Volume 4, Issue 10, pp. 806 - 813
Many solid tumours show an increased interstitial fluid pressure (IFP), which forms a barrier to transcapillary transport. This barrier is an obstacle in... 
RADIATION RESPONSE | DRUG PENETRATION | SOLID TUMORS | ONCOLOGY | COLLAGEN GEL CONTRACTION | PERICYTE RECRUITMENT | HUMAN OSTEOSARCOMA XENOGRAFTS | BLOOD-VESSELS | EXPERIMENTAL CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | BASEMENT-MEMBRANE | Extracellular Fluid - physiology | Humans | Alprostadil - pharmacology | Neoplasms - blood supply | Bradykinin - antagonists & inhibitors | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Hydrostatic Pressure | Neoplasms - drug therapy | Hyaluronoglucosaminidase - pharmacology | Animals | Biological Transport | Signal Transduction - drug effects | Transforming Growth Factor beta - antagonists & inhibitors | Antineoplastic Agents - pharmacokinetics | Mice | Neoplasms - physiopathology | Niacinamide - pharmacology | Platelet-Derived Growth Factor - antagonists & inhibitors | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Care and treatment | Research | Health aspects | Methods | Cancer | Alprostadil/pharmacology | Niacinamide/pharmacology | Bradykinin/antagonists & inhibitors | Signal Transduction/drug effects | Hyaluronoglucosaminidase/pharmacology | Neoplasms/blood supply/drug therapy/physiopathology | Tumor Necrosis Factor-alpha/antagonists & inhibitors | Platelet-Derived Growth Factor/antagonists & inhibitors | Antineoplastic Agents/pharmacokinetics | Extracellular Fluid/physiology | Transforming Growth Factor beta/antagonists & inhibitors | Research Support; Non-U.S. Gov't | Vascular Endothelial Growth Factor A/antagonists & inhibitors
Journal Article
Prostaglandins, Leukotrienes and Essential Fatty Acids, ISSN 0952-3278, 2012, Volume 87, Issue 2, pp. 79 - 89
Abstract The chick chorioallantoic membrane (CAM) subserves gas exchange in the developing embryo and shell-less culture affords a unique opportunity for... 
Endocrinology & Metabolism | Advanced Basic Science | Vasoactivity | E prostanoid receptors | Thromboxane receptors | Microsomes - metabolism | Estrogens - pharmacology | Misoprostol - pharmacology | Xanthones - pharmacology | Receptors, Prostaglandin - metabolism | Dose-Response Relationship, Drug | Microsomes - drug effects | alpha-Linolenic Acid - pharmacology | Biphenyl Compounds - pharmacology | Chorioallantoic Membrane - drug effects | Receptors, Thromboxane - antagonists & inhibitors | Prostaglandin Antagonists - pharmacology | Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide - pharmacology | Receptors, Prostaglandin - antagonists & inhibitors | Estradiol - pharmacology | Chorioallantoic Membrane - blood supply | Vasoconstrictor Agents - pharmacology | Dinoprostone - pharmacology | Hydrazines - pharmacology | Alprostadil - antagonists & inhibitors | Vasoconstrictor Agents - antagonists & inhibitors | Alprostadil - pharmacology | Rats | Chorioallantoic Membrane - metabolism | Chick Embryo | Vasoconstriction - drug effects | Animals | Receptors, Prostaglandin - agonists | Receptors, Thromboxane - agonists | 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid - pharmacology | Blood Vessels - drug effects | Receptors, Thromboxane - metabolism | Blood Vessels - physiology | Dinoprostone - antagonists & inhibitors | Thromboxanes | Blood vessels | Lipids | Prostaglandin E1 | Antagonists | Embryos | Fatty acids | Misoprostol | Chorioallantoic membrane | Leukotrienes | Models | Gas exchange | Prostaglandin E | Acute effects
Journal Article
Circulation, ISSN 0009-7322, 10/2004, Volume 110, Issue 16, pp. 2326 - 2332
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 04/2006, Volume 207, Issue 1, pp. 261 - 270
Recent evidence indicates that cyclooxygenase‐2 (COX‐2) and epidermal growth factor receptor (EGFR) are involved in hepatocarcinogenesis. This study was... 
Proto-Oncogene Proteins c-met - metabolism | RNA, Small Interfering - genetics | src-Family Kinases | Gene Expression - genetics | Protein-Tyrosine Kinases - metabolism | Caproates - pharmacology | Humans | Receptors, Prostaglandin - metabolism | Receptors, Prostaglandin E - genetics | Alprostadil - analogs & derivatives | Cell Movement - physiology | Membrane Proteins - analysis | Receptor, Epidermal Growth Factor - metabolism | Receptors, Prostaglandin - genetics | Transfection | RNA Interference | Cyclooxygenase 2 - genetics | Carcinoma, Hepatocellular - genetics | Protein Binding - drug effects | Liver Neoplasms - pathology | Membrane Proteins - metabolism | Phosphorylation - drug effects | Proto-Oncogene Proteins - metabolism | Dinoprostone - pharmacology | Bridged Bicyclo Compounds - pharmacology | Liver Neoplasms - genetics | Membrane Proteins - genetics | Neoplasm Invasiveness | Alprostadil - pharmacology | Cyclooxygenase 2 - analysis | Receptors, Prostaglandin E - physiology | Cell Movement - drug effects | Carcinoma, Hepatocellular - pathology | Cyclooxygenase 2 - metabolism | Liver Neoplasms - metabolism | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Protein Kinase Inhibitors - pharmacology | Receptors, Prostaglandin E, EP1 Subtype | Enzyme Activation | Carcinoma, Hepatocellular - metabolism
Journal Article
Journal Article
Journal Article
Circulation Research, ISSN 0009-7330, 01/2005, Volume 96, Issue 1, pp. e1 - e6
There is concern that cyclooxygenase (COX)-2 inhibitors may promote atherothrombosis by inhibiting vascular formation of prostacyclin (PGI2) and an increased... 
CARDIAC & CARDIOVASCULAR SYSTEMS | CYCLOOXYGENASE-2 | PROSTACYCLIN | cyclooxygenase | RECEPTOR | ARTERIAL THROMBOSIS | smooth muscle cells | CYCLIC-AMP | thrombosis | INHIBITION | GENE | thrombomodulin | ENDOTHELIAL-CELLS | DISEASE | prostaglandins | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | CARDIOVASCULAR RISK | Oligonucleotide Array Sequence Analysis | Humans | Gene Expression Profiling | Cyclooxygenase Inhibitors - toxicity | Thrombomodulin - biosynthesis | RNA, Messenger - biosynthesis | Carotid Artery Diseases - pathology | Myocytes, Smooth Muscle - drug effects | Carotid Artery, Internal - chemistry | Dinoprostone - pharmacology | Cells, Cultured - drug effects | Second Messenger Systems - drug effects | Sulfones - toxicity | Thrombophilia - physiopathology | Colforsin - pharmacology | Myocytes, Smooth Muscle - enzymology | Alprostadil - pharmacology | Sulfonamides - pharmacology | Receptors, Prostaglandin E, EP3 Subtype | Carotid Artery, Internal - enzymology | Membrane Proteins | Epoprostenol - analogs & derivatives | Pyridines - toxicity | Thrombophilia - blood | Carotid Artery Diseases - enzymology | Mammary Arteries - cytology | Models, Biological | Prostaglandins - deficiency | Receptors, Prostaglandin E - antagonists & inhibitors | Thrombophilia - chemically induced | Cells, Cultured - metabolism | Diclofenac - pharmacology | Tetradecanoylphorbol Acetate - pharmacology | Iloprost - pharmacology | Cyclooxygenase 2 | Culture Media, Serum-Free | Alprostadil - analogs & derivatives | Isoquinolines - pharmacology | Epoprostenol - pharmacology | Thrombomodulin - genetics | Myocytes, Smooth Muscle - cytology | Myocytes, Smooth Muscle - metabolism | Receptors, Prostaglandin - antagonists & inhibitors | Saphenous Vein - cytology | Vasodilator Agents - pharmacology | RNA, Messenger - genetics | Gene Expression Regulation - physiology | Gene Expression Regulation - drug effects | Cyclooxygenase 2 Inhibitors | Coronary Vessels - cytology | Bucladesine - pharmacology | Blood Coagulation - physiology | Prostaglandin-Endoperoxide Synthases - physiology
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 07/2007, Volume 5, Issue 7, pp. 1545 - 1551
Journal Article
FASEB Journal, ISSN 0892-6638, 08/2004, Volume 18, Issue 11, pp. 1318 - 1320
Journal Article